TalmetacinAlternative Names: BA 760506
Latest Information Update: 13 Aug 2004
At a glance
- Originator Bago; Resfar
- Class Analgesics; Antipyretics; Nonsteroidal anti-inflammatories
- Mechanism of Action Cyclooxygenase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Rheumatic disorders
Most Recent Events
- 13 Aug 2004 No development reported - Registered for Rheumatic disorders in Argentina (PO)
- 20 Feb 1997 Registered for Rheumatic disorders in Argentina (PO)